Your institution may have access to this item. Find your institution then sign in to continue.
Title
Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa.
Abstract
This Medical Letter review summarizes clinical studies, adverse effects, dosage, and administration for a 6% otic suspension formulation of the fluoroquinolone antibiotic ciprofloxacin (Otiprio), approved by the US Food and Drug Administration in 2018 for single-dose treatment of acute otitis externa.